Urgent

Acute / early HIV infection - recognition & treatment

Acute HIV · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Acute retroviral syndrome (seroconversion illness): a mononucleosis-like illness ~2-4 weeks after exposure - fever, rash, pharyngitis, lymphadenopathy. Patients are highly infectious. A 4th-generation Ag/Ab test can be negative in the earliest window, so diagnose with HIV RNA. Treat all - start ART as soon as possible (even same day).

Red flags

  • Aseptic meningitis / encephalitis
  • Severe or prolonged symptoms; very high viral load
  • Pregnancy
  • Opportunistic infection suggesting advanced disease
  • Recent long-acting cabotegravir PrEP (INSTI resistance risk)

Assessment

Differential diagnosis

  • EBV / CMV mononucleosis
  • Influenza / other acute viral illness
  • Secondary syphilis
  • Streptococcal pharyngitis
  • Drug reaction
  • Acute toxoplasmosis
  • Dengue / other travel-related febrile illness

Investigations

  • 4th-generation HIV Ag/Ab combination test AND HIV RNA (viral load) - RNA needed because antibody may be negative in early infection
  • Confirm/repeat per testing algorithm
  • Baseline CD4, HIV resistance genotype
  • HBV/HCV and STI screen
  • Pregnancy test in those of childbearing potential before ART

Management

  • Consider acute HIV in anyone with a mono-like/febrile illness +/- rash and risk factors - do not miss it (antibody may be negative)
  • Send HIV RNA, not antibody alone
  • Counsel on very high transmissibility
  • Treat all - start ART as soon as possible (even same-day); do not delay for resistance results
  • Choose an integrase-based regimen; if recent long-acting cabotegravir PrEP exposure, use a boosted PI pending genotype
  • Link urgently to HIV care; partner notification and PEP/PrEP counselling

Drugs & doses

Bictegravir/tenofovir-AF/emtricitabine - preferred single-tablet regimen
OR dolutegravir + tenofovir (DF or AF) + (emtricitabine or lamivudine)
Boosted darunavir + tenofovir + (FTC or 3TC) - if INSTI resistance concern (e.g. partner failing an INSTI regimen, or recent long-acting cabotegravir PrEP exposure) pending resistance results
Start ART as soon as possible (even same-day); continue indefinitely without interruption
Standard adult fixed-dose combinations - per-mg doses not itemised in source

Disposition

Urgent HIV/ID linkage for same-day/rapid ART start; admit if neurologic involvement or OI; public-health partner notification.

Complications & pitfalls

  • Ongoing onward transmission
  • Disease progression
  • Rare acute-phase opportunistic infections
  • Neurologic involvement (aseptic meningitis)

Exam pearls

  • In early infection the antibody test can be negative - order HIV RNA whenever you suspect seroconversion
  • Treat all and start ART immediately - improves outcomes, shrinks the reservoir, and cuts transmission
  • Recent long-acting cabotegravir PrEP exposure -> favour a boosted PI pending genotype
  • Do not delay ART for resistance results; adjust later if needed

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.